BDBM26060 4-methyl-2-[(1-phenyl-1H-1,2,3,4-tetrazol-5-yl)sulfanyl]-1,3-thiazole-5-carboxylic acid::BI-83C8
SMILES: Cc1nc(Sc2nnnn2-c2ccccc2)sc1C(O)=O
InChI Key: InChIKey=OKSOZDWPGNSYGR-UHFFFAOYSA-N
Data: 2 IC50
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mitogen-activated protein kinase 8 (Homo sapiens (Human)) | BDBM26060 (4-methyl-2-[(1-phenyl-1H-1,2,3,4-tetrazol-5-yl)sul...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | Article PubMed | n/a | n/a | >1.00E+5 | n/a | n/a | n/a | n/a | 7.5 | 22 |
Burnham Institute for Medical Research | Assay Description Compounds were tested for their ability to inhibit JNK1 phosphorylation of ATF2 in the Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET)... | Proc Natl Acad Sci U S A 105: 16809-13 (2008) Article DOI: 10.1073/pnas.0805677105 BindingDB Entry DOI: 10.7270/Q22N50K9 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Mitogen-activated protein kinase 8 (Homo sapiens (Human)) | BDBM26060 (4-methyl-2-[(1-phenyl-1H-1,2,3,4-tetrazol-5-yl)sul...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | Article PubMed | n/a | n/a | 7.50E+3 | n/a | n/a | n/a | n/a | 7.8 | 0 |
Burnham Institute for Medical Research | Assay Description Compound was evaluated for its ability to disrupt the interaction of pepJIP1 with JNK1 by using DELFIA assay. DELFIA is a heterogeneous assay whereby... | Proc Natl Acad Sci U S A 105: 16809-13 (2008) Article DOI: 10.1073/pnas.0805677105 BindingDB Entry DOI: 10.7270/Q22N50K9 | |||||||||||
More data for this Ligand-Target Pair |